Sudarshan Pharma Industries Ltd

Wed 2/09/2026,16:1:0 | BSE : SUDARSHAN

₹39.400.79 (2.05%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 38.50

Previous Close

₹ 38.61

Volume

3796000

Mkt Cap ( ₹ Cr)

₹ 948.20

High

₹ 39.40

Low

₹ 38.00

52 Week High

₹ 42.79

52 Week Low

₹ 18.50

Book Value Per Share

₹ 6.68

Dividend Yield

₹ 0.00

Face Value

₹₹1.00

What's Your Call?

Collective community sentiment on Sudarshan Pharma Industries Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sudarshan Pharma Industries Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sudarshan Pharma - Reg. 34 (1) Annual Report.

    29 Aug 2026, 2:49PM Pursuant to Reg 34 of SEBI Listing Regulations, please find enclosed the Annual Report of the Company for the FY 2025-26.

  • Sudarshan Pharma - Reg. 34 (1) Annual Report.

    29 Aug 2026, 2:47PM Pursuant to Reg 34 of SEBI Listing Regulations, please find enclosed the Annual Report of the Company for the FY 2025-26.

  • Sudarshan Pharma - Annual General Meeting Of The Company On Tuesday, 22/September/2026

    29 Aug 2026, 2:31PM Pursuant to Regulation 34 of SEBI Listing Regulations, please find enclosed the Notice of 18th Annual General Meeting to be held on Tuesday, 22/Septem

  • Sudarshan Pharma Q1 net profit jumps 61.93% at Rs 6.04 cr

    27 Aug 2026, 7:40PM The company reported standalone net profit of Rs 6.04 crore for the quarter ended June 30, 2026 as compared to Rs 3.73 crore in the same period last y

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Allotment

    19 Aug 2026, 6:45PM It is hereby informed that the members of the FCCB COmmittee of the COmpany, have at their meeting held today, 19/Aug/2026, have approved allotment of

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    18 Aug 2026, 12:40PM Pursuant to Regulation 30 of SEBI LODR Regulations, We hereby submit the updated Investor Presentation

  • Sudarshan Pharma - FCCB Committee Meeting On Wednesday, 19-August-2026

    14 Aug 2026, 4:29PM A Meeting of the FCCB Committee of the Company is scheduled on Wednesday, 19-August-2026 to consider and approve conversion a portion of funds raised

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 Aug 2026, 12:47PM We hereby submit the presentation on the manufacturing plant proposed to be acquired by the Company.

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Acquisition

    13 Aug 2026, 5:34PM The Company has entered into a Memorandum of Understanding to acquire 1,24,64,000 equity shares of Rs.10/- each of the target company (76% of paid up

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

    13 Aug 2026, 5:28PM The Board of Directors at their Meeting held on 12/August/2026 approved the divestment of 2,09,100 equity shares (51.00% of paid up share capital) of

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Acquisition

    13 Aug 2026, 5:23PM The Board of Directors at their meeting held on 12/August/2026 approved to acquire 3,000 equity shares (30.00% of paid up capital) of Sudarshan Maven

  • Sudarshan Pharma - Financial Results For The Quarter Ended 30/06/2026

    12 Aug 2026, 8:15PM Please find attached the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/06/2026

  • Sudarshan Pharma has submitted to BSE the Shareholding Pattern for the Period Ended August 03, 2026

    10 Aug 2026, 4:30PM As of August 2026, 58.93% is owned by Indian Promoters and 41.07% by Public. <p align=justify> Top five Promoters holding highest number of shares of

  • Sudarshan Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 8:30PM As of June 2026, 58.93% is owned by Indian Promoters and 41.07% by Public. <p align=justify> Top five Promoters holding highest number of shares of Su

  • Sudarshan Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 11:25AM Please find attached copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations, 2018, received from Kfin Technolog

  • Sudarshan Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    25 Jun 2026, 5:31PM Please find enclosed the Scrutinizer's Report on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from

  • Sudarshan Pharma - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    25 Jun 2026, 5:26PM Please find enclosed the voting results on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from 26/Ma

  • Sudarshan Pharma - Board Meeting Outcome for Board Meeting Scheduled On Thursday, 18 June 2026 Cancelled

    18 Jun 2026, 3:30PM We would like to inform you that the Meeting of the Board of Directors of the COmpany scheduled today, Thursday, 18/June/2026 stands cancelled due to

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Allotment

    12 Jun 2026, 8:01PM Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, the Warrants Committee of the Board of Director

  • Sudarshan Pharma - Meeting Of Warrants Committee Of The Company Scheduled On Thursday, 11/June/2026 Now Postponed To Friday,

    11 Jun 2026, 5:43PM We wish to inform you that the meeting of the Warrants Committee of the Company originally scheduled on 11/June/2026 has been postponed and will now b

  • Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    10 Jun 2026, 3:59PM This is to inform you that Sudarshan Industries Inc. has been incorporated as a wholly-owned subsidiary in United States of America. \r\n\r\nDetails p

  • Sudarshan Pharma - Meeting Of Warrants Committee Of The Company On Thursday, 11/June/2026

    8 Jun 2026, 7:50PM Pursuant to Regulation 29 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, a Meeting of the Warrants Committee of the Comp

  • Sudarshan Pharma - Intimation As Per Regulation 31 (1) & 31 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Reg

    5 Jun 2026, 9:12PM Please find enclosed disclosure under Regulation 31(2) of SEBI (Subtsantial Acquisition of Shares and Takeovers) REgulations, 2011 in connection with

  • Sudarshan Pharma - Reply To The Email Dated 18Th May 2026 Seeking 'Discrepancies In Financial Results'

    4 Jun 2026, 6:09PM We refer to email dated 18/May/2026, referring to discrepancies in financial results for the QUARTER and financial year ended 31/March/2026. \r\n\r\nW
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Sudarshan Pharma Industries Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 433.7945 304.2687 218.505 135.0755 60.3629
Liabilities 433.7945 304.2687 218.505 135.0755 60.3629
Equity 24.0659 24.0659 24.0659 24.0659 9.749
Gross Profit 48.9676 38.5027 22.6045 14.6916 10.92
Net Profit 21.9816 15.877 11.3553 7.0398 5.2524
Cash From Operating Activities -2.7522 34.906 7.9492 -28.7907 -3.7022
NPM(%) 3.29 3.15 2.43 1.52 1.47
Revenue 667.4985 502.5065 465.5623 461.3319 357.0946
Expenses 618.5309 464.0038 442.9578 446.6403 346.1746
ROE(%) 13.67 9.87 7.06 4.38 3.26

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sudarshan Pharma Industries Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 874.00 0.44 22.05 22.04 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 109.05 0.05 1542.57 80.29 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.55 -0.26 0.00 166.72 -39.50 0.00
Astec Lifesciences Ltd 572.25 1.05 0.00 86.03 -363.14 0.00

Company Info

The Company was originally incorporated on July 23, 2008 as a Private Limited Company as "Sudarshan Speciality Chemsolve Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited" under the Companies Act, 2013 pursuant to a special resolution passed by our shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Subsequently, pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on December 12, 2016 the Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of the Company was changed to `Sudarshan Pharma Industries Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on January 05, 2017 by the Registrar of Companies, Mumbai. The Corporate Identification Number of the Company is U51496MH2008PLC184997.MAJOR EVENTS AND MILESTONES:Year Particulars2008 -Incorporation of the company in the name and style of "Sudarshan Specialty Chemsolve Private Limited"2011 -Generic formulations for institution supply, NGO's and wholesale market2012 -Branded Generic formulations in Maharashtra2013 -Established the footprints in Gujarat, West Bengal, Chhattisgarh and Uttar Pradesh2014 -Introduced brands in New Drug Delivery System2015 -Over 5,000 medical practitioners associated with SPIL2016 -Company's name was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited"-7 own branded products introduced successfully in Vimac2017 -Conversion of the Company from Private Limited Company to Public Limited Company and Change of name of Company to Sudarshan Pharma Industries Limited2018 -Brand Brilliance Award from Asian African leadership forum in Pharma2019 -Launch Hart Kit Loading Dose and Hart Kit-42021 -VD-Section Got 50.00 cr. Government order (Started work on CORONA protection) 2024-The Company has splits its face value from Rs. 10/- to Rs. 1/-.2025-The Acquisition of Sudarshan Pharma Industries Private Limited.

The Company was originally incorporated on July 23, 2008 as a Private Limited Company as "Sudarshan Speciality Chemsolve Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited" under the Companies Act, 2013 pursuant to a special resolution passed by our shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Subsequently, pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on December 12, 2016 the Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of the Company was changed to `Sudarshan Pharma Industries Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on January 05, 2017 by the Registrar of Companies, Mumbai. The Corporate Identification Number of the Company is U51496MH2008PLC184997.MAJOR EVENTS AND MILESTONES:Year Particulars2008 -Incorporation of the company in the name and style of "Sudarshan Specialty Chemsolve Private Limited"2011 -Generic formulations for institution supply, NGO's and wholesale market2012 -Branded Generic formulations in Maharashtra2013 -Established the footprints in Gujarat, West Bengal, Chhattisgarh and Uttar Pradesh2014 -Introduced brands in New Drug Delivery System2015 -Over 5,000 medical practitioners associated with SPIL2016 -Company's name was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited"-7 own branded products introduced successfully in Vimac2017 -Conversion of the Company from Private Limited Company to Public Limited Company and Change of name of Company to Sudarshan Pharma Industries Limited2018 -Brand Brilliance Award from Asian African leadership forum in Pharma2019 -Launch Hart Kit Loading Dose and Hart Kit-42021 -VD-Section Got 50.00 cr. Government order (Started work on CORONA protection) 2024-The Company has splits its face value from Rs. 10/- to Rs. 1/-.2025-The Acquisition of Sudarshan Pharma Industries Private Limited.

Parent Organisation

Sudarshan Pharma Industries Ltd.

Founded

23/07/2008

Managing Director

Mr.Hemal Vasantrai Mehta

NSE Symbol

FAQ